新发血栓性微血管病中的钙调神经磷酸酶抑制剂毒性——罪魁祸首是我们所想的那样吗？ - Suppr | 超能文献

Calcineurin inhibitor toxicity in de novo thrombotic microangiopathy-Is the culprit what we think it is?

作者信息

Petr Vojtech, Zahradka Ivan, Viklicky Ondrej

机构信息

Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

出版信息

Am J Transplant. 2024 Sep;24(9):1708-1709. doi: 10.1016/j.ajt.2024.04.014. Epub 2024 Apr 25.

DOI:10.1016/j.ajt.2024.04.014

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Calcineurin inhibitor toxicity in de novo thrombotic microangiopathy-Is the culprit what we think it is?新发血栓性微血管病中的钙调神经磷酸酶抑制剂毒性——罪魁祸首是我们所想的那样吗？

Am J Transplant. 2024 Sep;24(9):1708-1709. doi: 10.1016/j.ajt.2024.04.014. Epub 2024 Apr 25.

2

Tacrolimus-induced thrombotic microangiopathy: natural history of a severe, acute vasculopathy.他克莫司诱导的血栓性微血管病：一种严重急性血管病的自然病程

Clin Nephrol. 2012 Jan;77(1):79-84. doi: 10.5414/cn107036.

3

De novo tacrolimus-induced thrombotic microangiopathy in the early stage after renal transplantation successfully treated with conversion to everolimus.肾移植术后早期新发他克莫司诱导的血栓性微血管病经转换为依维莫司成功治疗。

Pediatr Nephrol. 2015 Apr;30(4):693-7. doi: 10.1007/s00467-014-3036-8. Epub 2015 Jan 12.

4

Eculizumab for drug-induced de novo posttransplantation thrombotic microangiopathy: A case report.依库珠单抗治疗药物性新发移植后血栓性微血管病：一例报告

Clin Nephrol. 2015 Feb;83(2):125-9. doi: 10.5414/CN108163.

5

A case of tacrolimus-associated thrombotic microangiopathy after ABO-blood-type-incompatible renal transplantation.一例 ABO 血型不合肾移植后他克莫司相关性血栓性微血管病。

Clin Transplant. 2011 Jul;25 Suppl 23:15-8. doi: 10.1111/j.1399-0012.2011.01453.x.

6

De Novo Thrombotic Microangiopathy Immediately After Kidney Transplant in Patients Without Apparent Risk Factors.无明显危险因素的患者肾移植后立即发生的新发血栓性微血管病

Exp Clin Transplant. 2016 Apr;14(2):230-4. doi: 10.6002/ect.2014.0089. Epub 2015 May 30.

7

Thrombotic Microangiopathy Associated with Calcineurin Inhibitors: A Real-World Analysis of Postmarketing Surveillance Data.与钙调神经磷酸酶抑制剂相关的血栓性微血管病：上市后监测数据的真实世界分析

Clin Ther. 2025 Feb;47(2):117-122. doi: 10.1016/j.clinthera.2024.11.017. Epub 2024 Dec 16.

8

Neurologic Complications of the Central Nervous System after Allogeneic Stem Cell Transplantation: The Role of Transplantation-Associated Thrombotic Microangiopathy as a Potential Underreported Cause.异基因干细胞移植后中枢神经系统的神经并发症：移植相关血栓性微血管病作为潜在漏报病因的作用。

Transplant Cell Ther. 2024 Jun;30(6):586.e1-586.e11. doi: 10.1016/j.jtct.2024.03.017. Epub 2024 Mar 19.

9

[Intestinal thrombotic microangiopathy after liver transplantation].[肝移植术后肠道血栓性微血管病]

Korean J Gastroenterol. 2011 Mar;57(3):198-200. doi: 10.4166/2011.57.3.198.

10

Belatacept and Eculizumab for Treatment of Calcineurin Inhibitor-induced Thrombotic Microangiopathy After Kidney Transplantation: Case Report.贝拉西普和依库珠单抗治疗肾移植后钙调神经磷酸酶抑制剂诱导的血栓性微血管病：病例报告

Transplant Proc. 2016 Nov;48(9):3106-3108. doi: 10.1016/j.transproceed.2016.04.005.

引用本文的文献

1

Conservative Management of Thrombotic Microangiopathy in a Renal Transplant Recipient: The Importance of Early Recognition.肾移植受者血栓性微血管病的保守治疗：早期识别的重要性

Clin Case Rep. 2025 Mar 27;13(4):e70351. doi: 10.1002/ccr3.70351. eCollection 2025 Apr.